
Fluidigm Corporation FLDM
Fluidigm Corporation ROA Ratio | FLDM
Annual ROA Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -16.33 | -24.47 | -19.43 | -21.07 | -24.8 | -14.37 | -12.96 | -14.14 | -16.73 | -28.33 |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -12.96 | -28.33 | -19.26 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
VolitionRx Limited
VNRX
|
-338.45 | $ 0.16 | -1.97 % | $ 20.1 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M | ||
|
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
8.6 | $ 25.18 | 0.76 % | $ 564 M | ||
|
Twist Bioscience Corporation
TWST
|
-11.61 | $ 103.2 | -7.54 % | $ 6.46 B | ||
|
Organovo Holdings
ONVO
|
-187.42 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
62.07 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Renalytix AI plc
RNLX
|
-419.67 | - | 5.66 % | $ 22.7 M | ||
|
Meridian Bioscience
VIVO
|
9.17 | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | ||
|
T2 Biosystems
TTOO
|
-143.91 | - | -39.35 % | $ 313 K | ||
|
Syneos Health
SYNH
|
3.25 | - | - | $ 4.46 B | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
-64.5 | - | -11.32 % | $ 1.1 M | ||
|
Brainsway Ltd.
BWAY
|
3.1 | $ 8.53 | -2.29 % | $ 290 M | ||
|
Burning Rock Biotech Limited
BNR
|
-6.75 | $ 13.46 | 1.05 % | $ 142 M | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 609.81 | -3.81 % | $ 17.6 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
-6.46 | - | - | $ 608 M | ||
|
RadNet
RDNT
|
-0.5 | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
-22.37 | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
31.62 | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-40.31 | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
10.24 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
4.33 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
13.19 | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
-67.95 | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Celcuity
CELC
|
-37.95 | $ 53.32 | -5.31 % | $ 2.49 B | ||
|
Guardant Health
GH
|
-20.67 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
-35.87 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
3.33 | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
4.54 | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
-4.18 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
23.41 | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
12.79 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
-8.68 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
3.33 | $ 28.63 | -2.22 % | $ 27.1 B |